Dispensable sequence motifs in the RAG-1 and RAG-2 genes for

plasmid V(D)J recombination by Silver, Daniel P. et al.
Recombination
Dispensable Sequence Motifs in the RAG-1 and RAG-2 Genes for Plasmid V(D)J
DP Silver, E Spanopoulou, RC Mulligan, and D Baltimore 
doi:10.1073/pnas.90.13.6100 
 1993;90;6100-6104 PNAS
 This information is current as of December 2006.
 www.pnas.org#otherarticles
This article has been cited by other articles: 
 E-mail Alerts
. click herebox at the top right corner of the article or
Receive free email alerts when new articles cite this article - sign up in the
 Rights & Permissions
 www.pnas.org/misc/rightperm.shtml
To reproduce this article in part (figures, tables) or in entirety, see: 
 Reprints
 www.pnas.org/misc/reprints.shtml
To order reprints, see: 
 Notes:
Proc. Natl. Acad. Sci. USA
Vol. 90, pp. 6100-6104, July 1993
Immunology
Dispensable sequence motifs in the RAG-I and RAG-2 genes for
plasmid V(D)J recombination
(recombination activating genes/cysteine-rich motifs/topoisomerase homology)
DANIEL P. SILVER*t, EUGENIA SPANOPOULOUI, RICHARD C. MULLIGAN*t, AND DAVID BALTIMOREf
*Whitehead Institute for Biomedical Research, 9 Cambridge Center, Cambridge, MA 02142; tDepartment of Biology, Massachusetts Institute of Technology,
Cambridge, MA 02142; and tThe Rockefeller University, 1230 York Avenue, New York, NY 10021
Contributed by David Baltimore, February 22, 1993
ABSTRACT As a probe ofwhetherRAG-I andRAG-2 gene
products activate other genes or form part of the recombinase
itself, certain mutants of the RAG genes were assayed for their
ability to activate variable-diversity-joining region [V(D)J1
recombination in a plasmid substrate in fibroblasts. The results
indicate that the N-terminal one-third of RAG-I, induding a
zinc-finger-like domain, and an acidic domain of RAG-2 are
dispensable for activating V(D)J recombination in a fibroblast,
although they contribute quantitatively. In contrast, deletion of
the C-terminal segment of RAG-I, which has homology to a
topoisomerase-like protein from yeast, abolished recombina-
tion activation. These results do not support the hypothesis that
the RAG gene products are transcription factors and suggest
the possibility that they are parts of the recombination ma-
chinery.
The RAG-I and RAG-2 genes were identified and cloned by
virtue of their ability to induce 3T3 fibroblasts to conduct the
normally lymphocyte-specific process of variable-diversity-
joining region [V(D)J] recombination, the proper joining of
antibody gene segments by DNA recombination (1-3). Their
indispensable role in V(D)J recombination was verified by the
lack of such recombination in either B orT cells after ablative
mutation of either the RAG-I or RAG-2 genes (4, 5). The
biochemical processes carried out by the two proteins, how-
ever, remain to be elucidated. They could be developmental
switch genes for transcriptionally activating V(D)J recombi-
nation, analogous to MyoD and other myogenic genes that
activate events of muscle development (6). More likely, the
RAG proteins themselves could be part of the recombination
machinery. By this latter interpretation, the RAG-I and
RAG-2 gene products would be the only components of the
V(D)J recombinase machinery lacking in 3T3 fibroblasts, and
supplying them by transfection would activate recombination
directly. Models that fall between these two extremes are
also possible; for example, it is possible that one of the RAG
genes is an activator of the expression of other genes and the
other RAG gene functions as part of the recombinase ma-
chinery directly.
Although the protein sequences translated from the DNA
of the two genes do not give any direct indication of their
function, there are recognizable motifs that could imply
functional abilities. The RAG-1 protein sequence contains a
Cys-His motif shared by at least 20 other proteins (7, 8). This
motif (aa 290-328 of RAG-1) may have two zinc fingers
separated by one residue, but the first potential finger differs,
to our knowledge, from all others previously described
(9-11). Some proteins with the motif, including VZ61, IE110,
CG30, and RPT-1, are putative transcription factors (12-15),
although none at this point has been shown unequivocally to
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be a DNA-binding transcriptional activator or repressor and
no function for this motif has been determined.
RAG-2 contains a very acidic stretch of sequence (aa
270-410) (3). This stretch is reminiscent of the acidic acti-
vating domain of some transcription factors (16). The zinc-
finger-like domain of RAG-1 and the acidic stretch ofRAG-2
suggest that the proteins could function as transcription
factors, either separately or as a complex.
There is also evidence from the protein sequence suggest-
ing that RAG-1 is a component of the recombinase machin-
ery. The C-terminal half ofRAG-1 has sequence similarity to
the yeast protein HPRI (17), which has sequence similarity to
yeast topoisomerase I (18). Topoisomerases catalyze trans-
esterification reactions and are, therefore, similar to recom-
binases.
To establish which structural features of the RAG-1 and
RAG-2 proteins are important for V(D)J recombination,
mutants were constructed and assayed for their ability to
promote the recombination of an extrachromosomal test
substrate in fibroblasts. We find the features of RAG-1 and
RAG-2 that suggest that they may be transcription factors are
ones that are not necessary for V(D)J recombination activity,
although the region of RAG-1 that is similar in sequence to
HPR1 is necessary for function. These data suggest that the
RAG genes are not likely to be transcription factors but,
rather, might be components of the V(D)J recombination
machinery.
MATERIALS AND METHODS
Plasmids. The cDNA expression vector for the wild-type
RAG-1 cDNA and for all the RAG-1 mutants is identical to
the M2 cDNA expression vector based on CDM8 as de-
scribed (2) except that the 3' untranslated sequences of the
RAG-1 cDNA were removed starting from the Xcm I site 10
bp downstream of the stop codon. The expression vector for
the wild-type RAG-2 cDNA, in which all mutations were
introduced, is identical to the RAG-2 cDNA CDM8 vector as
described (3). To construct the RAG-I gene-containing ret-
rovirus, the RAG-1 cDNA was inserted into the recombinant
retroviral vector pMFG (P. Robbins, L. Spain, and R.C.M.,
unpublished data) such that the AUG of RAG-I was con-
verted into an Nco I site. In addition the Xcm I site just
downstream of the RAG-I stop codon was converted into a
BamHI site for cloning into pMFG. The retrovirus containing
the RAG-2 gene was also constructed using the retroviral
vector pMFG (see above). In this case, the AUG of RAG-2
was reconstructed to allow its cloning into an Nco I site, and
the Ase I site at the stop codon was adapted to provide a full
stop codon and a BamHI site for cloning into pMFG. (Com-
plete structures are available from the authors on request.)
Mutagenesis. All site-directed mutagenesis employed the
Bio-Rad Muta-Gene kit according to the manufacturer's
Abbreviation: V(D)J, variable-diversity-joining region.
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instructions with the following changes. The wild-type
RAG-1 or RAG-2 expression vectors in CDM8 (described
above) were introduced into the dut ung Escherichia coli BW
3I3/P3 (a gift of B. Seed, Harvard University School of
Medicine). After recovery of the uracil-substituted single-
stranded template and polymerization of a second strand
from a primer containing a mutation, the DNA was trans-
formed into E. coli XS127 (res- mod+). To create deletions
of the N terminus of the RAG-1 protein, the silent mutations
T39G and A42G were introduced to create unique Nar I and
Kas I restriction sites, which were used as starting points for
all deletions extending downstream. To construct the RAG-1
protein internal deletion of aa 299-330, the silent mutation
T894G creating a BamHI site was introduced. To construct
the RAG-2 protein internal deletion of aa 374-414, the silent
mutation T1116C creating an Xma I site was introduced. The
structure of the mutants was confirmed by restriction map-
ping, where possible, and sequencing. Two isolates of each
mutation were obtained to reduce the possibility of uninten-
tional second-site mutations having a significant effect.
Transient V(D)J Recombination Assays. 3T3 cells infected
with the RAG-I- or RAG-2-containing MFG retroviruses
were prepared by first cotransfecting the ecotropic retroviral
packaging cell line cre (19) with the appropriate retroviral
vector and pSV2Neo. Supernatants from the highest-titer
neomycin-selected /cre producer colonies were used to
infect 3T3 cells. A 3T3 cell population infected with the
RAG-2 gene-containing retrovirus was transfected with 6 ug
of the wild-type or mutant RAG-1 cDNA expression vector
and 10 ug of the V(D)J recombination reporter construct
pJH200 (20). For RAG-2 mutants, a 3T3 cell population
infected with the RAG-I-containing retrovirus was trans-
fected with 8 pg of the mutant cDNA expression vector and
10 pg of pJH200. Subsequent steps were as described (3),
except that the Dpn I-digested DNA was transformed into E.
coli MC 1061 by a calcium chloride procedure (21). The
colony filter hybridization with signal joint oligonucleotide
probe was as in ref. 3, except that the filter membranes used
were Hybond-N (Amersham).
Transfection of 293T Cells. 293T cells were transfected by
a modified calcium phosphate procedure (W. Pear and D.B.,
unpublished data).
Western Blot Analysis. Extracts were prepared from trans-
fected 293T cells 48 h after DNA was added and fractionated
by electrophoresis through a SDS/12.5% polyacrylamide gel.
The gel contents were transferred to nitrocellulose, probed
with anti-RAG-1 monoclonal antibody (E.S., unpublished
data) diluted 1:200 with 3% (wt/vol) nonfat dry milk, and
developed with horseradish peroxidase-conjugated anti-
mouse immunoglobulin antibody (Amersham) diluted 1:1000.
The membrane was visualized with the ECL chemilumines-
cence kit (Amersham) according to the manufacturer's in-
structions.
Indirect Immunofluorescence. The indirect immunofluores-
cence was a variation of that described in ref. 22 and will be
described elsewhere (E.S., unpublished data).
RESULTS
Passage and Expression of RAG-1 and RAG-2 in Retroviral
Vectors. To create cell populations that stably express either
RAG-1 or RAG-2, the RAG cDNAs were cloned into a
retroviral vector, MFG (P. Robbins, L. Spain, and R.C.M.,
unpublished results). The resulting plasmids, MFGR1 (the
RAG-I retrovirus) and MFGR2 (the RAG-2 retrovirus), were
separately transfected into the retroviral packaging line shr-re
(19) with pSV2neo as a selectable marker and clones that
produced the highest levels of virus were selected (data not
shown).
Populations of3T3 cells infected with supernatants derived
from the producer lines ofMFGR1, MFGR2, or both MFGR1
and MFGR2 showed greater than single copy integration by
Southern blot (Fig. 1). To examine whether the cells infected
with the viruses were able to make functional RAG-I and
RAG-2 gene products, a transient recombination assay was
performed in which the plasmid pJH200 (20)-which confers
chloramphenicol resistance to E. coli only after the recom-
bination signal sequences have been joined in a V(D)J re-
combination event-was transfected into the virally infected
3T3 cell populations. Forty-eight hours later, episomal DNA
was prepared from the transfected cells and transformed into
bacteria to score for recombinants. Only bacterial colonies
that were doubly resistant to ampicillin and chloramphenicol
and hybridized to an oligonucleotide probe containing a
signaljoint were counted. Transient recombination assays on
3T3 populations infected with both MFGR1 andMFGR2 gave
a high frequency of recombination, whereas transient assays
in populations singly infected with either MFGR1 or MFGR2
gave no recombination (Table 1). From this result it is evident
that the retroviral vectors provide sufficient levels of expres-
sion of both RAG genes to promote V(D)J recombination
within the test substrate.
Recombination Activity of Mutants. To assess the recom-
bination activity ofRAG-I mutants, a population of 3T3 cells
previously infected with MFGR2 was cotransfected with a
plasmid expression vector encoding the mutant and the
recombination test substrate pJH200. The MFGR2-infected
3T3 population gave an overall recombination frequency of
0.9% when cotransfected with the expression plasmid en-
coding wild-type RAG-I, CDM8R1, and pJH200. In similar
experiments, MFGRi-infected 3T3 cells gave an overall
recombination frequency of 0.21% when cotransfected with
the wild-type RAG-2 expression plasmid CDM8R2 and
pJH200. By comparison, 3T3 cells infected with both MFGR1
and MFGR2 gave a recombination frequency of 6.09% when
transfected with pJH200. The lower recombination frequen-
cies observed when transfecting one of the RAG genes may
reflect lower expression of a transfected gene than a resident
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FIG. 1. Gel transfer hybridization showing passage and titer of
RAG-I- and RAG-2-containing retroviral vectors. Genomic DNA
from 3T3 cells infected with supernatant containing the RAG-I- or
RAG-2-encoding retroviruses MFGR1 or MFGR2 was digested with
the restriction enzyme Nhe I and separated by electrophoresis
through an agarose gel. The gel contents were transferred to a nylon
membrane and hybridized with either a RAGI or RAG2 coding
sequence probe. The integrated proviruses are expected to be cut
twice with Nhe I, once in each long terminal repeat. (Left) The
RAG-I probed blot. Lanes: 1, uninfected 3T3 DNA; 2, uninfected
3T3 DNA with MFGR1 plasmid DNA added to a level of one copy
per genome; 3, unselected 3T3 population infected with the MFGR1
virus; 4, unselected population of 3T3 cells infected with both the
MFGR1 and MFGR2 viruses. (Right) The RAG-2 probed blot.
Lanes: 1, unselected population of 3T3 cells infected with the
MFGR2 virus (underloaded relative to the other lanes judging from
the 8.7-kb endogenous RAG-2 band); 2, DNA from the same unse-
lected population of 3T3 cells infected with both MFGR1 and
MFGR2 that was shown in Left, lane 4; 3, DNA from uninfected 3T3
cells; 4, DNA from uninfected 3T3 cells with plasmid of the MFGR2
virus added to the level of one copy per 3T3 genome.
Immunology: Sflver et al.
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Table 1. V(D)J recombination activity of wild-type and mutant
RAGI and RAG-2 genes in 3T3 cells
No. of colonies %
Amp+/ total
Protein Cam+ Oligo+ Amp+ % rec rec
RAG-I mutants
RAG-1
No RAG-1
A15-79
A15-135
A15-172
A15-273
A15-330
A15-469
A15-502
A299-330
A699-end
A994-end
A1009-end
A1023-end
KK142,143IQ
C290S
H295D
D299E
H307N
H307N,C310S
R311S
P326G
C328S
Y330F
T335V
D336N
Y998F
RAG-2
No RAG-2
A374-414
S40A
T121A
K312Q
DDE405NNQ
MFGR1+2
215, 89
0, 5
35, 26
46, 51
101, 167
78, 45
61, 27
1, 0
3, 0
35, 17
3, 3
1, 1
167, 282
352, 362
92, 154
7, 3
30, 84
110, 119
24, 19
11, 8
63, 36
3, 15
8, 1
49, 43
42, 64
98, 64
39, 23
23
5
20
6
8
S
4
16,
O,
30,
33,
9,
7,
4,
214, 88
0, 0
35, 26
45, 50
99, 166
77, 45
61, 27
0, 0
0, 0
34, 15
0, 0
0, 0
165, 281
349, 358
91, 152
6, 3
30, 82
107, 117
24, 17
10, 7
62, 36
3, 15
8, 1
49, 43
42, 64
98, 63
37, 23
855, 493
617, 598
262, 261
528, 502
678, 887
565, 245
486, 380
419, 374
637, 514
924, 442
369, 449
501, 508
505, 391
604, 640
413, 698
331, 347
423, 943
467, 551
682, 600
457, 322
561, 408
236, 584
475, 133
342, 343
277, 392
629, 312
205, 247
RAG-2 mutants
14,
O,
28,
32,
8,
6,
4,
23
0
19
6
8
4
4
231, 466
266, 537
589, 407
653, 218
288, 178
154, 192
271, 348
1.00, 0.71
0, 0
0.53, 0.41
0.34, 0.40
0.58, 0.75
0.55, 0.73
0.50, 0.28
0, 0
0, 0
0.15, 0.14
0, 0
0, 0
1.31, 2.87
2.31, 2.24
0.88, 0.87
0.07, 0.03
0.28, 0.35
0.92, 0.85
0.14, 0.11
0.09, 0.09
0.44, 0.35
0.05, 0.10
0.07, 0.03
0.57, 0.50
0.61, 0.65
0.62, 0.81
0.72, 0.37
0.24, 0.20
0, 0
0.19, 0.19
0.20, 0.11
0.11, 0.18
0.16, 0.08
0.06, 0.05
0.90
0.00
0.47
0.37
0.68
0.60
0.41
0.00
0.00
0.14
0.00
0.00
1.99
2.27
0.87
0.05
0.33
0.88
0.13
0.09
0.40
0.09
0.06
0.54
0.63
0.68
0.53
0.21
0.00
0.19
0.17
0.14
0.12
0.05
Double infection
144 143 94 6.09
RAG-I wild-type and mutant expression plasmids were transiently
transfected with the V(D)J recombination reporter pJH200 into a
population of 3T3 cells infected with the retrovirus MFGR2 that
expresses RAG-2 activity. Forty-eight hours later, episomal DNA
was prepared and transformed into bacteria, and the bacteria were
plated on ampicillin (Amp) orampicillin plus chloramphenicol (Amp/
Cam) plates. All mutants were isolated independently in duplicate,
and separate plasmid preparations were assayed in this manner. The
protein column shows the structure of the protein assayed. The
Amp+/Cam+ and Amp+ columns show the number of bacterial
colonies growing on plates with those drugs. The Oligo+ column
shows the number of colonies on the Amp/Cam plates that hybrid-
ized with the signal joint oligonucleotide probe. The percent recom-
bination (% rec) column shows the percent of signaljoint hybridizing
colonies to Amp+ colonies, taking into account that 25-fold more
bacteria were plated on the Amp/Cam plates than on the Amp plates.
In the Amp+/Cam+, Oligo+, Amp+, and % rec columns, each of the
two numbers shown refers to an independently picked mutant that
was assayed; the first number always refers to the first mutant. The
% total rec column was calculated by pooling the Oligo+ colonies and
Amp+ colonies to calculate a final percent recombination. RAG-2
mutants were treated identically, except they were transiently co-
transfected into a population of 3T3 cells infected with the RAGI-
expressing retrovirus MFGR1. For the double infection, a 3T3 cell
population infected with both the MFGR1 and MFGR2 retroviruses
was transfected with pJH200. The V(D)J recombination frequency
was calculated as above. A, deletion.
one, some miscoordination of the expression of the various
elements, or inefficient double transfection into the virally
infected cells. The low value, however, was well above the
background-which was <0.01o-and allowed the effects of
mutations to be measured.
A series of deletion mutants of the RAG-1 N terminus from
aa 15 toward the C terminus of the protein were assayed by
cotransfection of pJH200 and the expression plasmids en-
coding the mutants into 3T3 cells infected with MFGR2
(Table 1). Deletions of aa 15-79, 15-135, 15-172, 15-273, and
15-330 resulted in recombination frequencies -50%o of the
wild-type levels. Deletion of aa 15-330 completely encom-
passes the zinc-finger-like region, implying its dispensability
for recombination within the pJH200 plasmid. Deletion of aa
299-330, which spanned all but the first two cysteine residues
of the zinc-finger-like region, showed '15% of the activity of
wild-type RAG-1. Deletions of aa 15-469, 15-502, 15-581,
and 15-757 were all completely nonfunctional in the recom-
bination assay.
Deletions from the C terminus of the 1041-aa RAG-1
protein presented a different picture. Deletion of aa 1023-end
(aa 1041) and aa 1009-end gave approximately double the
wild-type rate of recombination, whereas deletions of aa
994-end and aa 699-end were both completely nonfunctional
in the transient recombination assay. Thus there is critical
sequence near the C terminus of RAG-1, the region related to
topoisomerase.
In addition, the results of point mutants targeted to various
structural features of RAG-1 were examined in the transient
recombination assay (Table 1). KK142,143IQ, a double mu-
tant in the putative nuclear localization signal (2), showed a
recombination frequency indistinguishable from wild type.
The set of point mutations in the Cys-His motif common to
RAG-1 and at least 20 other proteins all had similar effects:
C290S, H307N, H307N,C310S, P326G, and C328S all
showed levels of recombination 10- to 20-fold below wild-
type levels, but nevertheless all did produce V(D)J recom-
bination products that hybridized to a signal joint oligonu-
cleotide probe. Point mutations H295D, D299E, R311S,
Y330F, T335V, and D336N-in residues that are mostly
conserved among human, murine, chicken, and Xenopus
RAG-1 in the region of the zinc-finger-like motif-resulted in
recombination frequencies ranging from =33% to equal to
wild-type levels. A point mutant, Y998F, in a tyrosine residue
suggested to be homologous to the tyrosine in the active site
of type I and type II topoisomerases (17), gave -50% of the
level of recombination of the wild-type protein.
The recombination activity of several mutants of RAG-2
was also determined by transient assay (Table 1). A deletion
mutant of RAG-2, aa 374-414, which encompassed virtually
all of the acidic stretch of RAG-2, gave a recombination level
indistinguishable from that of wild-type RAG-2 when co-
transfected with pJH200 into a population of 3T3 cells
infected with MFGR1. As another test of the importance of
the acidic stretch of RAG-2, the triple point mutant made by
substituting NNQ for the wild-type sequences DDE (aa
405-407) in the acidic stretch was constructed. This mutant
showed a 4-fold reduction in recombination frequency com-
pared to wild-type RAG-2 but still was able to activate
recombination.
Various other point mutants of RAG-2 were constructed.
Mutant T121A removed a potential cAMP-dependent protein
kinase target site, S40A changed a region of very weak
sequence similarity to E. coli isoleucine tRNA ligase, and
K312Q altered a sequence of weak similarity to the E. coli
EcoRI methylase. None of these point mutants had dramatic
effects on recombination levels.
The various mutants were also examined for recombina-
tion levels in the highly transfectable cell line 293T both as a
way of confirming the results in 3T3 cells and because 293T
6102 Immunology: Sflver et al.
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cells were used to assay the stability of the mutant proteins
(see below). The recombination frequencies ofthe mutants of
RAG-1 and RAG-2 in 293T cells were in good agreement with
the data obtained in 3T3 cells (data not shown).
Stability and Expression of Mutants. To evaluate the sta-
bility of the mutant proteins, plasmids encoding wild-type
RAG-i and the RAG-i mutants were transfected into 293T
cells, and protein extracts were made 48 h after transfection
for Western blot analysis. Probing the filters with a mono-
clonal antibody raised against the C-terminal half of RAG-1
(E.S., unpublished data) revealed that the wild-type protein,
point mutants, and N-terminal deletion mutants were ex-
pressed and all migrated at the expected molecular masses
(Fig. 2). Furthermore, all of the N-terminal deletion mutants
with the exception of the aa 15-757 deletion were expressed
at higher levels than wild type, suggesting that a sequence in
the RNA or protein between aa 15 and aa 79 reduces
steady-state protein levels. None of the C-terminal mutants
was detected with the monoclonal antibody, suggesting that
its epitope is between aa 1024 and the C terminus of the
protein (aa 1041).
Subcellular Localization of Mutants. The subcellular local-
ization of a subset of the RAG-I mutants was determined by
indirect immunofluorescence. To achieve high enough ex-
pression to allow detection, these mutants were subcloned
into the MFG retrovirus and cotransfected with the ecotropic
replication-competent retrovirus ZAP into 293T cells. Viral
supernatant was collected 2 days later and used to infect 3T3
cells. These cells were passaged once and then permeabilized
and stained with anti-RAG-1 monoclonal antibody followed
by rhodamine-conjugated anti-mouse immunoglobulin. Cells
infected with virus carrying the wild-type RAG-I gene dis-
played a punctate nuclear staining (Fig. 3). The deletion
mutant of RAG-1 aa 299-330 and the RAG-1 mutant in the
putative nuclear localization site KK142,143IQ showed the
same distribution as the wild-type protein. The RAG-I point
mutants C290S and H307N in the zinc-finger-like region also
showed the wild-type pattern (data not shown). Other mu-
tations in the RAG-1 zinc-finger-like region displayed differ-
ent patterns of immunofluorescence. The majority of cells
infected with a virus carrying the double point mutant
H307N,C310S had a diffuse nuclear pattern of staining,
although some cells showed the same punctate nuclear stain-
ing as cells expressing the wild-type protein. The cells
expressing mutant P326G showed uniform nuclear staining
A
,4R
2 3 4 5 6 7 8 9 1C11
B
14 1..
FIG. 2. Expression ofthe RAG- deletion and point mutants. The
insoluble pellets from extracts resulting from transient transfection of
293T cells with expression plasmids for various RAGi mutants were
fractionated by electrophoresis through SDS/PAGE gels and trans-
ferred to nitrocellulose membranes. The membranes were probed
with a monoclonal antibody (E.S., unpublished data) and visualized
with a secondary horseradish peroxidase-conjugated antibody and
the chemilluminescent ECL system (Amersham). (A) Deletion mu-
tants. Lanes: 1, wild-type RAG-1; 2, deletion of aa 298-330; 3,
deletion of aa 15-79; 4, deletion of aa 15-135; 5, deletion of aa
15-172; 6, deletion of aa 15-273; 7, deletion of aa 15-330; 8, deletion
of aa 15-469; 9, deletion of aa 15-502; 10, deletion of aa iS-581; 11,
deletion of aa 15-757. (B) Point mutants (a longer exposure than in
A). Lanes: 12, KK142,143IQ; 13, C290S; 14, H295D; 15, D299E; 16,
H307N; 17, H307N,C31OS; 18, R3iiS; 19, P326G; 20, C328S; 21,
Y330F; 22, T335V; 23, D336N; 24, Y998F; 25, no RAGI.
WI
A299-330 KK 142143 10
M3U(N(A61Ub
FIG. 3. Indirect immunofluorescence of wild-type and mutant
RAG-1 proteins. Wild-type RAG-i and various mutants were cloned
into the retrovirus vector MFG. These plasmids were cotransfected
into 293T cells with a plasmid containing the ecotropic helper virus
ZAP. Forty-eight hours later, the supernatant from these cells was
used to infect 3T3 cells. Indirect immunofluorescence ofthe infected
3T3 cells was performed using RAG-1 monoclonal antibody (E.S.,
unpublished data) and a rhodamine-conjugated secondary antibody.
Wild-type RAG-i-infected cells and cells infected with the helper
virus alone (Rag-l-) are shown in the top panels. The other mutants
are as marked.
superimposed on a nuclear punctate pattern with perhaps
some cytoplasmic staining; some of the mutant C328S-
expressing cells showed a diffuse nuclear staining pattern,
whereas other cells showed the wild-type pattern. Cells
expressing the RAG-i mutant with the large N-terminal (aa
15-330) deletion showed staining throughout the nucleus and
cytoplasm, and some cells had in addition bright nuclear
spots.
DISCUSSION
Several lines of experimental evidence presented here sug-
gest that RAG-1 and RAG-2 are likely to be components of
the V(D)J recombination machinery, rather than transcrip-
tion factors that activate a set of genes whose products form
the V(D)J recombinase. (i) The region of RAG-I with se-
quence similarity to the yeast topoisomerase-like gene HPRI
is required for recombination. HPR1 suppresses intrachro-
mosomal recombination in yeast; perhaps RAG-1 directs the
same recombination machinery toward the substrates for
V(D)J recombination. (ii) The structural feature of RAG-1
Immunology: Sflver et al.
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resembling a DNA-binding motif of transcription factors, the
zinc-finger-like region, is not necessary to activate V(D)J
recombination in fibroblasts. Furthermore, the acidic stretch
of RAG-2, which resembles the acidic activation motif of
some transcription factors, is also not necessary for recom-
bination activity in fibroblasts.
The point mutants in the motif resembling a zinc finger in
RAG-1 (C290S, H307N, H307N,C310S, P326G, and C328S)
gave 5- to 10-fold lower recombination rates than that pro-
duced by the aa 15-330 deletion mutant that lacked the entire
motif. The mutants produced accurately recombined prod-
ucts with correct signal joints and, therefore, displayed no
defect other than a low rate, a result that would not be
expected if the "zinc finger" were involved as the DNA
recognition domain of a transcription factor. The point mu-
tations in the Cys-His motif might cause alterations in the
folding of that region that could interfere physically with the
proper functioning of the rest of the protein. However, the
point mutant proteins, like the wild-type protein, are present
in cells at lower levels than the aa 15-330 deletion mutant, as
judged by Western blot analysis (Fig. 2). Also, aa 299-330
deletion mutant has a recombination rate only slightly higher
than the point mutants, although this deletion removes most
of the zinc-finger-like motif but is expressed at levels com-
parable to the wild-type RAG-1 protein (Fig. 2, lane 2). Thus,
a reduced efficiency of recombination by all mutants inter-
fering with the zinc-finger motif, coupled with an increased
protein concentration for those mutants that have a deletion
spanning at least aa 15-79, is the probable explanation of the
recombinant percentages produced by these mutants. It
appears that this motif may help RAG-1 protein to function,
but it is clearly not absolutely essential, suggesting that it is
not directly involved in recognition or catalysis.
The subcellular loclization of overexpressed RAG-1 pro-
tein and of several of the mutants was determined by indirect
immunofluorescence. The wild-type RAG-1 protein localized
as bright spots within the nucleus. Because three proteins that
contain the zinc-finger-like motif, IEllO, Ro/SSA, and PML,
have been reported to localize in speckles in the nucleus
(23-25), the subcellular localization of several mutants in the
zinc-finger-like region has been determined. Some mutations
in the zinc-finger-like region did change the pattern of nuclear
localization. However, the observation that the aa 299-330
deletion mutant, which lacks all but the first two cysteines of
the motif, still displayed the wild-type pattern eliminates the
possibility that the motif is responsible for the speckled
nuclear distribution of the protein. The mutants in the zinc-
finger region that change the spatial pattern of expression in
the nucleus, H307N,C310S, P326G, and C328S, probably do
so because the folding of the N terminus of the protein is
perturbed. The mutations in the putative nuclear localization
sequence, KK142,143IQ, do not affect the subceilular local-
ization ofthe protein, indicating that other domains contribute
to the nuclear localization of the RAG-1 protein. The large
N-terminal deletion (aa 15-330), which is functional in a
recombination assay, does cause a substantial relocation of
much of the protein to the cytoplasm, so sequences specifying
subcellular localization are likely to be found in that region.
We found no consistent relationship between subcellular lo-
calization and recombinational activity.
It should be noted that the recombination assay used in
experiments presented here utilizes pJH200, an extrachro-
mosomal substrate that forms a signal joint (a heptamer-
heptamer fusion) after recombination. It is conceivable that
the zinc-finger-like motif of RAG-1 or the acidic region of
RAG-2 is required either for recombination in its proper
chromosomal context or to form coding joints.
Mutations at the C-terminal end ofRAG-1 are informative.
Deletion of the last 18 aa or 32 aa results in increased
recombination activity. Because our antibody reagents can-
not detect RAG-1 mutants missing the C terminus, the
mechanism by which activity is increased is not clear and
could be either enhanced expression or more efficient intrin-
sic activity in promoting recombination. Deletion of more
sequence from the C terminus of the protein results in no
recombination activity at all, suggesting that the C terminus
is required for RAG-1 activity. Because this is the region of
the protein with sequence similarity to the yeast topoi-
somerase-like protein HPR1, these results support the spec-
ulation that RAG-1 may have a mechanism of action similar
to that of HPR1. The suggestion has been made based on
structural similarities between HPR1 and various topoi-
somerases that HPR1 may in fact be a topoisomerase (17, 18).
This analysis suggested that Tyr-532 ofHPR1 would be at the
active site and be the amino acid that covalently bonds to the
phosphodiester backbone ofDNA. However, a point mutant
at the tyrosine residue of RAG-1 that corresponds to Tyr-532
of HPR1 does not abolish V(D)J recombination (RAG-1
Y998F, see Table 1). Clearly, if there are functional analogies
between HPR1 and RAG-1, these remain to be elucidated.
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